Collaboration is extremely important to us. Gaining new knowledge, both practical and theoretical, is also extremely important. For this reason, Magda went on a 6-month internship to Professor Alvaro Colina’s group in Burgos, Spain.
The cooperation turned out to be very successful because shortly after her return our first article in this cooperation was accepted1. In Bioelectrochemistry, we have described the redox properties of a new potential drug against Alzheimer’s disease, knows as TDMQ20. Collaboration with the group from Burgos allowed us to conduct spectroelectrochemical studies (SEC). Based on SEC, we were able to demonstrate what products are formed during the oxidation of a potential therapeutic molecule. This is important in terms of understanding the toxicity of the drug itself and redox stability in the brain of Alzheimer’s patients.
This is not our last word on this topic! We hope for another publication, so stay tuned for the future of TDMQ and Magda.
- M. Z. Wiloch, M. Perez-Estebanez, N. Baran, A. Heras, M. Jönsson-Niedziółka, A. Colina
Spectroelectrochemical studies of TDMQ20: A potential drug against Alzheimer’s disease, Bioelectrochem 161, 108814 (2024). (link – OA)
